Intercell AG - Hospital bug vaccine delayed

CompaniesHealth Care ♦ Published: May 18, 2010; 00:00 ♦ (Vindobona)

According to an announcement by Zoe Schneeweiss and Namoi Kresge (Bloomberg) Intercell AG fell the most in two weeks in Vienna, after stating that a vaccine against a deadly hospital bug may be delayed to the first or second quarter of 2011.

Intercell AG - Hospital bug vaccine delayed / Picture: © Intercell

Intercell declined 60 cents, or 3.4 percent, to close at €17.06, the biggest drop since June 4.

“We can’t really influence when it will be completed, since the study is being conducted by Merck & Co., who we partner with on this vaccine,” says Gerald Strohmaier, a spokesman for Intercell. The Vienna-based company said it expected the interim analysis of the vaccine…

Fast News Search